Profile
| Metric | Value |
|---|---|
| Full Name | Haemonetics Corporation |
| Ticker | NYSE: HAE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | haemonetics.com |
| Employees | 3,023 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $79.98 | |
| Price, 1D Change | -0.21% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | 23.33 | |
| Beta | 0.63 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +3.95% | |
| EPS | $3.31 | |
| EPS, 1Y Change | +44.51% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.31 | |
| EPS Estimate | N/A | $4.91 |
| EPS Est. Change | N/A | +48.67% |
| Revenue | $1.36B | |
| Revenue Estimate | N/A | $1.32B |
| Revenue Est. Change | N/A | -3.14% |
| Current Price | $79.98 | |
| Price Target | - | $90.00 |
| Price Tgt. Change | - | +12.53% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.96 | $2.29 | -42.24% | |
| $4.54 | $3.31 | -27.26% | |
| $4.91 | N/A | +48.67% | |
| $5.47 | N/A | +65.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.29B | $1.31B | +1.09% | |
| $1.36B | $1.36B | +0.09% | |
| $1.32B | N/A | -3.14% | |
| $1.40B | N/A | +2.63% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +2.02% | |
| Price, 3Y | +1.69% | |
| Market Cap, 1Y | -4.94% | |
| Market Cap, 3Y | -5.64% | |
| Revenue, 1Y | +3.95% | |
| Revenue, 3Y | +37.01% | |
| EPS, 1Y | +44.51% | |
| EPS, 3Y | +291.35% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $79.98 | |
| SMA 200 | $65.12 | |
| SMA 200 vs Price | -18.59% | |
| SMA 50 | $72.65 | |
| SMA 50 vs Price | -9.16% | |
| Beta | 0.63 | |
| ATR | $1.92 | |
| 14-Day RSI | 55.62 | |
| 10-Day Volatility | 7.47% | |
| 1-Year Volatility | 53.49% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.36B | |
| EPS | $3.31 | |
| Gross Profit | $715.33M | |
| Gross Margin | 52.57% | |
| Operating Profit | $222.34M | |
| Operating Margin | 16.34% | |
| Net Income | $167.68M | |
| Net Margin | 12.32% | |
| EBITDA | $337.93M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.56 | |
| Current Ratio | 1.62 | |
| Quick Ratio | 0.99 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 2.61 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 23.33 | |
| PS Ratio | 2.82 | |
| PB Ratio | 4.41 | |
| EV/EBITDA | 13.32 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $820.84M | |
| Cash & Equivalents | $306.76M | |
| Total Assets | $2.45B | |
| Current Assets | $934.98M | |
| Total Liabilities | $1.63B | |
| Current Liabilities | $578.11M | |
| Total Debt | $1.28B | |
| Short Term Debt | $311.67M | |
| Accounts Payable | $67.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.19B | |
| Operating Expenses | $492.99M | |
| Cost Of Goods Sold | $645.50M | |
| SG&A | $436.79M | |
| D&A | $115.59M | |
| Interest Expense | $0.00 | |
| Income Tax | $44.39M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $181.73M | |
| CFI | -$161.90M | |
| CFF | $108.82M | |
| Capex | $39.28M | |
| Free Cash Flow | $142.45M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Mizuho | → | |
| Needham | → | |
| Baird | → | |
| JP Morgan | → | |
| Citigroup | → | |
| BTIG | → | |
| Needham | → | |
| Barrington Research | → | |
| BTIG | → | |
| Barrington Research | → |
Analyst sentiment
Institutional ownership
Screeners with HAE
Data Sources & References
- HAE Official Website www.haemonetics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/313143/000031314325000075/0000313143-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/313143/000031314325000025/0000313143-25-000025-index.htm
- HAE Profile on Yahoo Finance finance.yahoo.com/quote/HAE
- HAE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hae
FAQ
What is the ticker symbol for Haemonetics Corporation?
The ticker symbol for Haemonetics Corporation is NYSE:HAE
Does Haemonetics Corporation pay dividends?
No, Haemonetics Corporation does not pay dividends
What sector is Haemonetics Corporation in?
Haemonetics Corporation is in the Healthcare sector
What industry is Haemonetics Corporation in?
Haemonetics Corporation is in the Medical Devices industry
What country is Haemonetics Corporation based in?
Haemonetics Corporation is headquartered in United States
When did Haemonetics Corporation go public?
Haemonetics Corporation initial public offering (IPO) was on May 10, 1991
Is Haemonetics Corporation in the S&P 500?
No, Haemonetics Corporation is not included in the S&P 500 index
Is Haemonetics Corporation in the NASDAQ 100?
No, Haemonetics Corporation is not included in the NASDAQ 100 index
Is Haemonetics Corporation in the Dow Jones?
No, Haemonetics Corporation is not included in the Dow Jones index
When was Haemonetics Corporation last earnings report?
Haemonetics Corporation's most recent earnings report was on November 6, 2025
When does Haemonetics Corporation report earnings?
The next expected earnings date for Haemonetics Corporation is February 5, 2026